Macrophagic myofasciitis: An emerging entity;La myofasciite a macrophages: Une nouvelle entite

Revue de Medecine Interne

Volumn 19, Issue 9, 1998, Pages 617-618

  Gherardi, R K ^a   Cherin, P ^a   Authier, J ^a   Belec, L ^a   Beon, C ^a   Coquet, M ^a   Combe, B ^a   Desnuelle, C ^a   Doutre, A M ^a   Eymard, B ^a   Fardeau, M ^a   Figarella Branger, D ^a   Hachulla, E ^a   Herson, S ^a   Miossec, P ^a   Mussini, J M ^a   Pellissier, J F ^a   Stadler, J F ^a   Urtizberea, J A ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Fasciitis; Histiocytosis; Inflammatory myopathy; Macrophage

Indexed keywords

DERMATOMYOSITIS; EDITORIAL; FASCIITIS; HISTIOCYTOSIS; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE FUNCTION; MUSCLE BIOPSY; MUSCLE DISEASE; MYOPATHY; POLYMYOSITIS; FRANCE; MACROPHAGE; MEDICAL SOCIETY; PATHOLOGY;

FASCIITIS; FRANCE; HISTIOCYTOSIS; HUMANS; MACROPHAGES; MUSCULAR DISEASES; SOCIETIES, MEDICAL;

EID: 0032160612     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(99)80039-3     Document Type: Editorial

References (5)

1. Dalakas MC Polymyositis, dermatomyositis and inclusion body myositis N Engl J Med 325 1991 1487 1488
2. Naschitz JE Boss JH Misselevitch I Yeshurun D Rosner I The fasciitis-panniculitis syndromes. Clinical and pathologic features Medicine 75 1996 6 16
3. Mayeno AN Benson LM Naylor S Colberg-Beers M Puchalski JT Gleich GJ Biotransformation of 3(phenylamino) 1,2-propanediol to 3- (phenylamino) alanine: a chemical link between toxic oil syndrome and eosiniphilia-myalgia syndrome Chem Res Toxicol 8 1995 911 916
4. sous presse Gherardi RK Coquet M Chérin P Authier FJ Laforêt P Belec L Macrophagic myofasciitis: an emerging entity Lancet 1998
5. Schwartz DA Emerging and reemerging infections. Progress and challenges in the subspecialty of infectious disease pathology Arch Pathol Lab Med 121 1997 776 784